Ozempic face is a term used to describe facial changes that can occur after rapid weight loss from GLP-1 medications
Their global presence and partnerships support market expansion
There is no evidence to support regular calcitonin testing (a tumour marker for medullary thyroid carcinoma) or thyroid ultrasound surveillance in asymptomatic patients taking these medications
What this means for you If you have Aetna Medicare Advantage, your current options are: Coverage for type 2 diabetes (Mounjaro may be covered) Coverage for moderate-to-severe OSA with BMI (body mass index) 27 (Medicare may cover unlike commercial Aetna) [12] Self-pay options: TrumpRx ($346/month), LillyDirect ($299-$449/month), or Foundayo (oral GLP-1, ~$149/month) Medicare GLP-1 Coverage Coming 2026 TrumpRx: Federal direct-to-consumer program launched February 6, 2026 offering Zepbound at ~$346/monthavailable to anyone including Medicare beneficiaries
We have long left behind the eat less, move more nonsense that unfortunately pervades much of the fitness and weight loss industry
(1) you can click a link on the confirmation (2)or you can receive our email with your download(s)